A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS

被引：0
|
作者：
Montalban, Xavier [1 ]
Hemmer, Bernhard [2 ,3 ]
Rammohan, Kottil W. [4 ]
Giovannoni, Gavin [5 ]
De Seze, Jerome [6 ]
Bar-Or, Amit [7 ]
Arnold, Douglas L. [7 ,8 ]
Sauter, Annette [9 ]
Masterman, Donna [10 ]
Fontoura, Paulo [9 ]
Chin, Peter [11 ]
Garren, Hideki [9 ]
Wolinsky, Jerry S. [12 ]
机构：
[1] Hosp Vall dHebron Univ, Barcelona, Spain
[2] Tech Univ Munich, D-80290 Munich, Germany
[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[4] Univ Miami, Miami, FL USA
[5] Queen Mary Univ London, London, England
[6] Univ Hosp Strasbourg, Strasbourg, France
[7] McGill Univ, Montreal, PQ, Canada
[8] NeuroRx Res, Montreal, PQ, Canada
[9] F Hoffmann La Roche & Co Ltd, Basel, Switzerland
[10] Genentech Inc, San Francisco, CA 94080 USA
[11] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
[12] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P023
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Dichlorphenamide for the Treatment of Periodic Paralysis: a Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
    Burge, James
    Sansone, Valeria
    McDermott, Michael
    Smith, Patty
    Herr, Barbara
    Tawil, Alrabi
    Pandya, Shree
    Kissel, John
    Ciafaloni, Emma
    Shieh, Perry
    Ralph, Jeffrey
    Amato, Anthony
    Cannon, Stephen
    Trivedi, Jaya
    Barohn, Richard
    Crum, Brian
    Mitsumoto, Hiroshi
    Pestronk, Alan
    Meola, Giovanni
    Conwit, Robin
    Jasek, Mark
    Hanna, Michael
    Griggs, Robert
    NEUROLOGY, 2016, 86
  • [2] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    Respiratory Research, 21
  • [3] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [4] The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
    Sha, Zhongwei
    Hou, Yiping
    Xue, Chunchun
    Li, Ou
    Li, Zhimin
    Wang, Huiru
    Zhang, Wenjing
    Xu, Jian
    TRIALS, 2020, 21 (01)
  • [5] The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
    Zhongwei Sha
    Yiping Hou
    Chunchun Xue
    Ou Li
    Zhimin Li
    Huiru Wang
    Wenjing Zhang
    Jian Xu
    Trials, 21
  • [6] Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
    Keary, Christopher
    Bird, Lynne M.
    de Wit, Marie-Claire
    Hatti, Shivkumar
    Heimer, Gali
    Heussler, Helen
    Kolevzon, Alexander
    Mathews, Adera
    Ochoa-Lubinoff, Cesar
    Tan, Wen-Hann
    Yan, Ying
    Adams, Maxwell
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 47 : 6 - 12
  • [7] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Pasquale Caponnetto
    Davide Campagna
    Jasjit S. Ahluwalia
    Christopher Russell
    Marilena Maglia
    Paolo Marco Riela
    Carmelo Fabio Longo
    Barbara Busa
    Riccardo Polosa
    BMC Medicine, 21
  • [8] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Caponnetto, Pasquale
    Campagna, Davide
    Ahluwalia, Jasjit S.
    Russell, Christopher
    Maglia, Marilena
    Riela, Paolo Marco
    Longo, Carmelo Fabio
    Busa, Barbara
    Polosa, Riccardo
    BMC MEDICINE, 2023, 21 (01)
  • [9] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [10] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
12345